ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
101,640.89
0.44%
S&P 500
6,069.34
-0.24%
Dow Jones
44,063.81
-0.19%
US Dollar vs Yen
152.1725
-0.06%
Brent Oil
73.46
0.02%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Generation Bio Company (GBIO)

  7. Generation Bio Company (GBIO) ニュース

GBIO

Generation Bio (GBIO)

Generation Bio Company
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:GBIO
日付受信時刻ニュースソース見出しコード企業名
2024/11/0706 : 16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GBIOGeneration Bio Company
2024/11/0706 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GBIOGeneration Bio Company
2024/11/0706 : 05GlobeNewswire Inc.Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial ResultsNASDAQ:GBIOGeneration Bio Company
2024/10/2406 : 04Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:GBIOGeneration Bio Company
2024/10/2219 : 59GlobeNewswire Inc.Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual CongressNASDAQ:GBIOGeneration Bio Company
2024/10/1805 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/10/1805 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/10/1805 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/10/1805 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/10/1805 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/09/1305 : 05GlobeNewswire Inc.Generation Bio to Present at the 2024 Cantor Global Healthcare ConferenceNASDAQ:GBIOGeneration Bio Company
2024/08/1613 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GBIOGeneration Bio Company
2024/08/0805 : 31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GBIOGeneration Bio Company
2024/08/0805 : 15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GBIOGeneration Bio Company
2024/08/0805 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GBIOGeneration Bio Company
2024/08/0805 : 05GlobeNewswire Inc.Generation Bio Reports Second Quarter 2024 Financial ResultsNASDAQ:GBIOGeneration Bio Company
2024/08/0619 : 59GlobeNewswire Inc.Generation Bio to Present at the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:GBIOGeneration Bio Company
2024/07/1805 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/07/1805 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/07/1805 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/07/1805 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/07/1805 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/06/1419 : 59GlobeNewswire Inc.Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA SummitNASDAQ:GBIOGeneration Bio Company
2024/06/1105 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/06/0805 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GBIOGeneration Bio Company
2024/05/1405 : 15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GBIOGeneration Bio Company
2024/05/1405 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GBIOGeneration Bio Company
2024/05/1405 : 05GlobeNewswire Inc.Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial ResultsNASDAQ:GBIOGeneration Bio Company
2024/05/0919 : 59GlobeNewswire Inc.Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual MeetingNASDAQ:GBIOGeneration Bio Company
2024/04/2306 : 31GlobeNewswire Inc.Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual MeetingNASDAQ:GBIOGeneration Bio Company
 Showing the most relevant articles for your search:NASDAQ:GBIO

最近閲覧した銘柄

NYSE
NKE
Nike
NASDAQ
MSFT
Microsoft
SPI
SP500
S&P 500
CCOM
US500
US 500
FX
USDGBP
US Dollar vs Sterling
COIN
BTCUSD
Bitcoin
NYSE
MCD
McDonalds
AMEX
XLV
Health Care Select Sector
NYSE
JPM
JP Morgan Chase
USOTC
ADDYY
Adidas (QX)
NYSE
VZ
Verizon Communications
COIN
AVAXUSD
Avalanche
USOTC
BASFY
BASF (QX)
COIN
DOGEUSD
Dogecoin
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有